Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Intergroupe Francophone Du Myelome

Clinical trials sponsored by Intergroupe Francophone Du Myelome, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug teclistamab tested in patients with Hard-to-Treat myeloma Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 2

Could a drug combo replace chemo and transplant for multiple myeloma?

Disease control Recruiting now

This study tests whether a combination of two drugs (elranatamab and lenalidomide) can replace high-dose chemotherapy and stem cell transplant for people newly diagnosed with multiple myeloma. About 824 adults under 70 will be randomly assigned to either standard treatment or the…

Phase 3 • Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC